ResearcherMedical University of WarsawNo recent work listed

Marek Wroński

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-0941-4202; OpenAlex author ID A5065287736. Sources: ClinicalTrials.gov.

Their work

Papers: 1 (first author 1, last author 0)
Trials: 1 (principal investigator on 1)
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2016: 1 trial · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 1

Current Approaches for the Curative-Intent Surgical Treatment of Pancreatic Ductal Adenocarcinoma. First author DOI 10.3390/cancers15092584 ↗

Trials 1

Early Oral Versus Enteral Nutrition After Pancreatoduodenectomy Principal investigator NCT01642875 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Maciej Słodkowski · 1 shared paper, 1 shared trial, 2016–2023 · strength 0.41
- Paper Current Approaches for the Curative-Intent Surgical Treatment of Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers15092584 ↗
- Trial Early Oral Versus Enteral Nutrition After Pancreatoduodenectomy NCT01642875 ↗
Aneta Jachnis · 1 shared paper, 2023 · strength 0.22
- Paper Current Approaches for the Curative-Intent Surgical Treatment of Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers15092584 ↗
Leszek Kraj · 1 shared paper, 2023 · strength 0.22
- Paper Current Approaches for the Curative-Intent Surgical Treatment of Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers15092584 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.